Subsequently, the tert-butyl ester was solvolyzed with TFA in DCM and the sequence was repeated. By commencing with chloroacetic acid and finishing with chloride displacement by morpholine with potassium iodide in THF, the anticancer peptide drug, Carfilzomib (73), was accomplished in a nine-step linear protocol with 68% overall yield without epimerization.